Calciphylaxis Clinical Study Expands to the United Kingdom SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a clinical trial application...

Hope Pharmaceuticals Files Supplemental New Drug Application to the Food and Drug Administration for Sodium Thiosulfate Injection SCOTTSDALE, Ariz., June 07, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the company filed a Supplemental New Drug Application to the United States Food and Drug Administration...

First Canadian Calciphylaxis Subject to Participate in the CALISTA (Sodium Thiosulfate Injection) Clinical Study SCOTTSDALE, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced enrollment of the first Canadian subject to participate in the CALISTA clinical study that is evaluating...